Liquid Biopsy Market Size Estimated to Reach USD 3,051.1 Million in 2026: Roche Diagnostics, Illumina, Myriad Genetics, Genomic Health, QIAGEN
The global liquid biopsy market generated USD 1,006.31 Million in 2018 and is anticipated to grow at a CAGR of 14.9% during the forecast period.
View full press release